Page 20 - Trials Network News Today

Press release content from NewMediaWire. The AP news staff was not involved in its creation. GeoVax Receives Notice of Allowance for Hepatitis B Vaccine Patent GeoVax, Inc.April 1, 2021 GMT Therapeutic Vaccine Would Address Medical Need of Over 250 Million Worldwide Atlanta, GA - ( NewMediaWire ) - April 01, 2021 - GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer,...

Antibody Mediated Prevention (AMP) trials data published by the New England Journal of Medicine Most advanced clinical trials testing broadly neutralizing antibody against HIV demonstrate efficacy against sensitive strains Public Relations Pacific LLC  E-Mail SEATTLE - (EMBARGOED UNTIL MARCH 17, 2021, AT 5 P.M. ET) - The proof-of-concept AMP studies demonstrated that a broadly neutralizing antibody (bnAb) called VRC01 was effective at preventing the acquisition of HIV str...

Universal ‘test and treat’ an economically efficient strategy to help control HIV epidemic in southern Africa Universal ‘test and treat’ an economically efficient strategy to help control HIV epidemic in southern Africa 13 March 2021 London School of Hygiene & Tropical Medicine London School of Hygiene & Tropical Medicine https://lshtm.ac.uk/themes/custom/lshtm/images/lshtm-logo-black.png Package of HIV prevention methods can be d...

In trial, cabotegravir delayed detection of some incident HIV infections Source: Landovitz R, et al. Abstract 153LB. Presented at: Conference on Retroviruses and Opportunistic Infections; March 6-10, 2021 (virtual meeting). Disclosures: Landovitz reports serving on scientific advisory boards for Gilead Sciences and Merck and receiving honoraria from Roche. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your...

Monitoring and Evaluation Job in USA about Health, requiring 3-4 years of experience, from ICAP; closing on 05 Apr 2021

Forbes Africa Published 3 weeks ago At a time when science remains the only hope for humanity against a vindictive virus, the spotlight continues to be on those working tirelessly on the frontline. As the world observes international women’s day on March 8, FORBES AFRICA examines some of these intrepid women leading the charge with their services and solutions, combating dark nights and even darker days through the COVID-19 pandemic. BY CHANEL RETIEF AND SIMONE SRIBRATH WITHOUT A DOUBT, COV...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Registration Now Open For Tribe Public’s Webinar Event “Advancing a Unique Broad-based Vaccine ... GeoVax, Inc.March 1, 2021 GMT Tribe Event with GeoVax Labs, Inc. Tribe Event with GeoVax Labs, Inc. Meet with GeoVax CEO David Dodd & CFO Mark Reynolds who will Deliver a Presentation Titled “Advancing a Unique Broad-based Vaccine Approach to Fighting COVID-19, Ebola & Beyond” ATLANTA, GA, March ...

Biostatisticians draft blueprints for COVID-19 vax trials Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic February 18, 2021 • By Sabin Russell / Fred Hutch News Service Dr. Peter Gilbert (left) leads a team of Fred Hutch biostatisticians that pivoted to COVID-19 vaccine trial design. Dr. Holly Janes (right) is a co-principal investigator with Gilbert at the Statistical and D...

Questions ranged from vaccine ramp up plans, to equity, costs, and what comes next.

WSDOH says it's an effort to get more information out to people about the vaccine, when their window is, and more.